Personal-Use Self-monitoring Blood Glucose Devices Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 4.40 Billion |
| Market Size (2030) | USD 6.10 Billion |
| CAGR (2025 - 2030) | 6.75% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Personal-Use Self-monitoring Blood Glucose Devices Market Analysis
The Personal-Use Self-monitoring Blood Glucose Devices Market size is estimated at USD 4.40 billion in 2025, and is expected to reach USD 6.10 billion by 2030, at a CAGR of 6.75% during the forecast period (2025-2030).
Globally, the rising prevalence of diabetes, an aging population, and the increasing number of patients with multiple chronic diseases underscore the growing need for regular at-home diabetes monitoring, significantly driving the market's expansion.
Countries grappling with a high burden of patients suffering from multiple chronic diseases are witnessing a surge in demand for at-home self-blood glucose monitoring. For instance, a February 2024 article from the Centers for Disease Control and Prevention highlighted that approximately 129 million Americans are afflicted with major chronic diseases, including heart disease, cancer, diabetes, obesity, and hypertension in 2023. The article noted a steady rise in the prevalence of these chronic diseases over the past two decades, a trend poised to continue. Alarmingly, 42% of Americans grapple with two or more chronic conditions, and 12% contend with at least five. Given that these individuals often require long-term care and may be bed-ridden, accessing tests away from home becomes a challenge, emphasizing the value of at-home self-monitoring blood glucose tests.
Moreover, the global diabetes burden further fuels the market's growth. For instance, data from Australia's National Diabetes Services Scheme, published in June 2024, revealed a decade-long rise in diabetes prevalence, with approximately 1.48 million Australians living with various diabetes types as of March 2024. This significant diabetes prevalence highlights the critical demand for self-monitoring glucose meters, vital for effective disease management and driving market growth in a comprehensive manner.
The research studied highligting the need for home diabtes test is also boosting the growth of the market. For instance, in August 2024, a study in Lancet Diabetes and Endocrinology highlighted the potential of home-administered HbA1c tests in early pregnancy. This approach, especially beneficial for women in remote areas, facilitates timely interventions for gestational diabetes, reducing reliance on oral glucose tolerance tests (OGTTs). Early pregnancy HbA1c testing provides a simple screening method, enabling those at the highest risk to receive prompt care and intervention.
In summary, the escalating diabetes burden, research studies and the relentless pursuit of innovative products are propelling the market's growth. Yet, challenges loom, as a lack of awareness and subsequent low diagnosis rates could temper this momentum.
Personal-Use Self-monitoring Blood Glucose Devices Market Trends
The glucometer devices segment is expected to register the highest CAGR over the forecast period
Driven by rising adoption in home care, a shift towards self-monitoring, and the launch of advanced devices, the glucometer segment is poised for notable growth. Research endorsing at-home testing for various diabetes types further fuels this expansion.
Glucometers, essential for blood sugar monitoring, enable immediate care. Users apply a blood drop to a glucose-sensitive test strip. After inserting this strip into the meter, technologies like reflectance photometry or electrochemical methods determine the glucose level. While commonly used at home, these devices are also standard in clinical settings, with each new generation offering improved precision and accuracy.
The research study highlighting the added benefits associated with at home diabetes testing is also boosting the market segment's growth. For instance, Research from Singapore, published in BMC Primary Care in April 2024, highlighted the advantages of home HbA1c testing. The study found that 81.3% of participants valued the convenience of avoiding clinic visits. Such findings underscore the benefits of personal glucometer use, driving its wider adoption.
Market players are actively innovating home-use blood tests. South Korean startup Orange Biomed is preparing to launch its personal glycated hemoglobin (HbA1c) device globally. With a focus on diabetic households and pursuing FDA certification, Orange Biomed, in collaboration with a US clinical trial organization, is conducting both clinical and anticipated non-clinical tests, with approvals expected by mid-2025. These initiatives highlight the market's promising growth trajectory.
Thus, owing to the above-mentioned factors, such as development of innovative products, high burden of daibetes the glucometer segment of the market is expected to grow over the forecast period.
North America is expected to dominate the Personal-Use Self-monitoring Blood Glucose Devices Market Over the Forecast Period.
North America is poised for a significant rise in the market for self-monitoring blood glucose devices. This growth is driven by factors such as sedentary lifestyles, rising obesity rates, and a substantial geriatric population. The region's expansion is further supported by major industry players and government reimbursement initiatives aimed at making diabetes management more accessible to a broader population.
With the increasing diabetes cases in the region, the demand for self-monitoring blood glucose meters has surged, underscoring their importance in effective disease management. A report from the Centers for Disease Control and Prevention (CDC) in November 2024 highlighted that from August 2021 to August 2023, 15.8% of the U.S. population was affected by diabetes. The CDC detailed that 11.3% of U.S. adults were diagnosed, with an additional 4.5% undiagnosed. It also highlighted a gender disparity in the U.S. between August 2021 and August 2023. Men had higher diabetes rates, with 18.0% total prevalence and 12.9% diagnosed, while women had rates of 13.7% and 9.7%, respectively. The report also emphasized that diabetes prevalence, whether total, diagnosed, or undiagnosed, increased with age. This significant prevalence in the region's countries fuels the market's expansion.
Moreover, Canada's government initiatives for reimbursing diabetes supplies under Universal Healthcare are anticipated to further boost the market's growth. For example, in February 2024, the Canadian government introduced Bill C-64. The bill encompasses equipment for monitoring sugar levels, including glucometers, test strips, lancets, and both flash and continuous glucose monitoring devices (CGM). Utilizing CGM or Flash GM devices not only minimizes complications but also curtails long-term hospitalization costs. The bill also aims to ensure that individuals across all income levels have equitable access to these essential devices. Beyond the reimbursements from Bill C-64, the federal government plans to establish a fund dedicated to enhancing access to diabetes devices and supplies, which will further alleviate the financial burden on patients and improve overall diabetes management outcomes.
Given the significant diabetes burden in the region and proactive government initiatives, the market for personal use self-monitoring blood glucose devices is set to flourish in North America.
Personal-Use Self-monitoring Blood Glucose Devices Industry Overview
The global market for personal-use self-monitoring blood glucose devices is semi-consolidated, with a limited number of players operating at both global and regional levels, holding significant market shares. These market players are adopting various organic strategies, such as product innovation and portfolio expansion, as well as inorganic strategies, including mergers, acquisitions, and partnerships, to strengthen their positions. Some of the key players in this market include Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia Diabetes Care Holdings AG.
Personal-Use Self-monitoring Blood Glucose Devices Market Leaders
-
LifeScan Inc.
-
Arkray Inc.
-
Abbott
-
Ascensia Diabetes Care Holdings AG
-
F. Hoffmann-La Roche AG
- *Disclaimer: Major Players sorted in no particular order
Personal-Use Self-monitoring Blood Glucose Devices Market News
- January 2025: PT Diagnostics has launched the A1CNow SELF CHECK in the UK, empowering individuals to manage their diabetes in just five minutes from the comfort of their homes. This user-friendly device offers a quick and accurate way to obtain HbA1c results. By measuring glycated haemoglobin (HbA1c), individuals with both Type 1 and Type 2 diabetes can gauge their average blood sugar levels over the past 2-3 months.
- January 2025: Orange Biomed had showcased its groundbreaking device, 'OBM rapid A1c', at Eureka Park during CES 2025 in Las Vegas, Nevada, from January 7 to 10. 'OBM rapid A1c', employs microfluidic technology for glycated hemoglobin measurement. This innovative solution empowers users to effortlessly gauge their glycated hemoglobin levels at home using just a single drop of blood.
Personal-Use Self-monitoring Blood Glucose Devices Industry Segmentation
Personal use self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets at home setting. Based on the readings, patients can adjust or check the effect of their treatment.
The self-monitoring blood glucose device market is segmented into components and geography. By component, the market is further sub-segmented into Glucometer Devices, Test Strips, and Lancet. By Geography, the market is subsegmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report offers the value (in USD) for the above segments.
| Component | Glucometer Devices | ||
| Test Strips | |||
| Lancets | |||
| Geography | North America | United States | |
| Canada | |||
| Rest of North America | |||
| Europe | Germany | ||
| Spain | |||
| Italy | |||
| France | |||
| United Kingdom | |||
| Russia | |||
| Rest of Europe | |||
| Asia-Pacific | Japan | ||
| China | |||
| Australia | |||
| India | |||
| South Korea | |||
| Malaysia | |||
| Indonesia | |||
| Thailand | |||
| Philippines | |||
| Vietnam | |||
| Rest of Asia-Pacific | |||
| Latin America | Brazil | ||
| Mexico | |||
| Rest of Latin America | |||
| Middle East and Africa | South Africa | ||
| Saudi Arabia | |||
| Oman | |||
| Egypt | |||
| Iran | |||
| Rest of Middle East and Africa | |||
Personal-Use Self-monitoring Blood Glucose Devices Market Research FAQs
How big is the Personal-Use Self-monitoring Blood Glucose Devices Market?
The Personal-Use Self-monitoring Blood Glucose Devices Market size is expected to reach USD 4.40 billion in 2025 and grow at a CAGR of 6.75% to reach USD 6.10 billion by 2030.
What is the current Personal-Use Self-monitoring Blood Glucose Devices Market size?
In 2025, the Personal-Use Self-monitoring Blood Glucose Devices Market size is expected to reach USD 4.40 billion.
Who are the key players in Personal-Use Self-monitoring Blood Glucose Devices Market?
LifeScan Inc., Arkray Inc., Abbott, Ascensia Diabetes Care Holdings AG and F. Hoffmann-La Roche AG are the major companies operating in the Personal-Use Self-monitoring Blood Glucose Devices Market.
Which is the fastest growing region in Personal-Use Self-monitoring Blood Glucose Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Personal-Use Self-monitoring Blood Glucose Devices Market?
In 2025, the North America accounts for the largest market share in Personal-Use Self-monitoring Blood Glucose Devices Market.
What years does this Personal-Use Self-monitoring Blood Glucose Devices Market cover, and what was the market size in 2024?
In 2024, the Personal-Use Self-monitoring Blood Glucose Devices Market size was estimated at USD 4.10 billion. The report covers the Personal-Use Self-monitoring Blood Glucose Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Personal-Use Self-monitoring Blood Glucose Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Personal-Use Self-monitoring Blood Glucose Devices Industry Report
Statistics for the 2025 Personal-Use Self-monitoring Blood Glucose Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Personal-Use Self-monitoring Blood Glucose Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
